ATC drug classification of Canadian drugs

C CARDIOVASCULAR SYSTEM

C01 CARDIAC THERAPY

C01A CARDIAC GLYCOSIDES

C01AA Digitalis glycosides
C01AA05 - digoxin (Wiki, WHO)

C01B ANTIARRHYTHMICS, CLASS I AND III

C01BA Antiarrhythmics, class Ia
C01BA02 - procainamide (Wiki, WHO)
C01BA03 - disopyramide (Wiki, WHO)

C01BB Antiarrhythmics, class Ib
C01BB01 - lidocaine (Wiki, WHO)
C01BB02 - mexiletine (Wiki, WHO)

C01BC Antiarrhythmics, class Ic
C01BC03 - propafenone (Wiki, WHO)
C01BC04 - flecainide (Wiki, WHO)

C01BD Antiarrhythmics, class III
C01BD01 - amiodarone (Wiki, WHO)
C01BD02 - bretylium tosilate (Wiki, WHO)
C01BD05 - ibutilide (Wiki, WHO)
C01BD07 - dronedarone (Wiki, WHO)

C01BG Other antiarrhythmics, class I and III
C01BG11 - vernakalant (Wiki, WHO)

C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES

C01CA Adrenergic and dopaminergic agents
C01CA02 - isoprenaline (Wiki, WHO)
C01CA03 - norepinephrine (Wiki, WHO)
C01CA04 - dopamine (Wiki, WHO)
C01CA06 - phenylephrine (Wiki, WHO)
C01CA07 - dobutamine (Wiki, WHO)
C01CA17 - midodrine (Wiki, WHO)
C01CA24 - epinephrine (Wiki, WHO)
C01CA26 - ephedrine (Wiki, WHO)

C01CE Phosphodiesterase inhibitors
C01CE - phosphodiesterase inhibitors (Wiki, WHO)
C01CE02 - milrinone (Wiki, WHO)

C01D VASODILATORS USED IN CARDIAC DISEASES

C01DA Organic nitrates
C01DA02 - glyceryl trinitrate (Wiki, WHO)
C01DA08 - isosorbide dinitrate (Wiki, WHO)
C01DA14 - isosorbide mononitrate (Wiki, WHO)

C01E OTHER CARDIAC PREPARATIONS

C01EA Prostaglandins
C01EA01 - alprostadil (Wiki, WHO)

C01EB Other cardiac preparations
C01EB10 - adenosine (Wiki, WHO)
C01EB17 - ivabradine (Wiki, WHO)

C02 ANTIHYPERTENSIVES

C02A ANTIADRENERGIC AGENTS, CENTRALLY ACTING

C02AB Methyldopa
C02AB02 - methyldopa (racemic) (Wiki, WHO)

C02AC Imidazoline receptor agonists
C02AC01 - clonidine (Wiki, WHO)
C02AC02 - guanfacine (Wiki, WHO)

C02B ANTIADRENERGIC AGENTS, GANGLION-BLOCKING

C02C ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING

C02CA Alpha-adrenoreceptor antagonists
C02CA01 - prazosin (Wiki, WHO)
C02CA04 - doxazosin (Wiki, WHO)

C02D ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON

C02DB Hydrazinophthalazine derivatives
C02DB02 - hydralazine (Wiki, WHO)

C02DC Pyrimidine derivatives
C02DC01 - minoxidil (Wiki, WHO)

C02DD Nitroferricyanide derivatives
C02DD01 - nitroprusside (Wiki, WHO)

C02K OTHER ANTIHYPERTENSIVES

C02KX Other antihypertensives
C02KX - antihypertensives for pulmonary arterial hypertension (Wiki, WHO)
C02KX01 - bosentan (Wiki, WHO)
C02KX02 - ambrisentan (Wiki, WHO)
C02KX04 - macitentan (Wiki, WHO)
C02KX05 - riociguat (Wiki, WHO)

C02L ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION

C02N COMBINATIONS OF ANTIHYPERTENSIVES IN ATC-GR. C02

C03 DIURETICS

C03A LOW-CEILING DIURETICS, THIAZIDES

C03AA Thiazides, plain
C03AA03 - hydrochlorothiazide (Wiki, WHO)

C03B LOW-CEILING DIURETICS, EXCL. THIAZIDES

C03BA Sulfonamides, plain
C03BA04 - chlortalidone (Wiki, WHO)
C03BA08 - metolazone (Wiki, WHO)
C03BA11 - indapamide (Wiki, WHO)

C03BD Xanthine derivatives
C03BD - xanthine derivatives (Wiki, WHO)

C03C HIGH-CEILING DIURETICS

C03CA Sulfonamides, plain
C03CA01 - furosemide (Wiki, WHO)
C03CA02 - bumetanide (Wiki, WHO)

C03CC Aryloxyacetic acid derivatives
C03CC01 - etacrynic acid (Wiki, WHO)

C03D POTASSIUM-SPARING AGENTS

C03DA Aldosterone antagonists
C03DA01 - spironolactone (Wiki, WHO)
C03DA04 - eplerenone (Wiki, WHO)

C03DB Other potassium-sparing agents
C03DB01 - amiloride (Wiki, WHO)

C03E DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION

C03EA Low-ceiling diuretics and potassium-sparing agents
C03EA01 - hydrochlorothiazide and potassium-sparing agents (Wiki, WHO)

C03X OTHER DIURETICS

C03XA Vasopressin antagonists
C03XA01 - tolvaptan (Wiki, WHO)

C04 PERIPHERAL VASODILATORS

C04A PERIPHERAL VASODILATORS

C04AB Imidazoline derivatives
C04AB01 - phentolamine (Wiki, WHO)

C04AC Nicotinic acid and derivatives
C04AC01 - nicotinic acid (Wiki, WHO)

C04AD Purine derivatives
C04AD03 - pentoxifylline (Wiki, WHO)

C04AE Ergot alkaloids
C04AE01 - ergoloid mesylates (Wiki, WHO)

C05 VASOPROTECTIVES

C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE

C05AA Corticosteroids
C05AA01 - hydrocortisone (Wiki, WHO)
C05AA51 - hydrocortisone, combinations (Wiki, WHO)

C05AD Local anesthetics
C05AD01 - lidocaine (Wiki, WHO)
C05AD07 - pramocaine (Wiki, WHO)

C05AX Other agents for treatment of hemorrhoids and anal fissures for topical use
C05AX - other agents for treatment of hemorrhoids and anal fissures for topical use (Wiki, WHO)
C05AX03 - other preparations, combinations (Wiki, WHO)

C05B ANTIVARICOSE THERAPY

C05BA Heparins or heparinoids for topical use
C05BA04 - pentostan polysulfate sodium (Wiki, WHO)

C05BB Sclerosing agents for local injection
C05BB - sclerosingagents for local injection (Wiki, WHO)
C05BB02 - polidocanol (Wiki, WHO)
C05BB04 - sodium tetradecyl sulphate (Wiki, WHO)
C05BB56 - glucose, combinations (Wiki, WHO)

C05C CAPILLARY STABILIZING AGENTS

C07 BETA BLOCKING AGENTS

C07A BETA BLOCKING AGENTS

C07AA Beta blocking agents, non-selective
C07AA03 - pindolol (Wiki, WHO)
C07AA05 - propranolol (Wiki, WHO)
C07AA06 - timolol (Wiki, WHO)
C07AA07 - sotalol (Wiki, WHO)
C07AA12 - nadolol (Wiki, WHO)

C07AB Beta blocking agents, selective
C07AB02 - metoprolol (Wiki, WHO)
C07AB03 - atenolol (Wiki, WHO)
C07AB04 - acebutolol (Wiki, WHO)
C07AB07 - bisoprolol (Wiki, WHO)
C07AB09 - esmolol (Wiki, WHO)
C07AB12 - nebivolol (Wiki, WHO)

C07AG Alpha and beta blocking agents
C07AG01 - labetalol (Wiki, WHO)
C07AG02 - carvedilol (Wiki, WHO)

C07B BETA BLOCKING AGENTS AND THIAZIDES

C07C BETA BLOCKING AGENTS AND OTHER DIURETICS

C07CA Beta blocking agents, non-selective, and other diuretics
C07CA03 - pindolol and other diuretics (Wiki, WHO)

C07CB Beta blocking agents, selective, and other diuretics
C07CB03 - atenolol and other diuretics (Wiki, WHO)

C07D BETA BLOCKING AGENTS, THIAZIDES AND OTHER DIURETICS

C07E BETA BLOCKING AGENTS AND VASODILATORS

C07F BETA BLOCKING AGENTS AND OTHER ANTIHYPERTENSIVES

C08 CALCIUM CHANNEL BLOCKERS

C08C SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS

C08CA Dihydropyridine derivatives
C08CA01 - amlodipine (Wiki, WHO)
C08CA02 - felodipine (Wiki, WHO)
C08CA05 - nifedipine (Wiki, WHO)
C08CA06 - nimodipine (Wiki, WHO)

C08D SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS

C08DA Phenylalkylamine derivatives
C08DA01 - verapamil (Wiki, WHO)

C08DB Benzothiazepine derivatives
C08DB01 - diltiazem (Wiki, WHO)

C08E NON-SELECTIVE CALCIUM CHANNEL BLOCKERS

C08G CALCIUM CHANNEL BLOCKERS AND DIURETICS

C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM

C09A ACE INHIBITORS, PLAIN

C09AA ACE inhibitors, plain
C09AA01 - captopril (Wiki, WHO)
C09AA02 - enalapril (Wiki, WHO)
C09AA03 - lisinopril (Wiki, WHO)
C09AA04 - perindopril (Wiki, WHO)
C09AA05 - ramipril (Wiki, WHO)
C09AA06 - quinapril (Wiki, WHO)
C09AA07 - benazepril (Wiki, WHO)
C09AA08 - cilazapril (Wiki, WHO)
C09AA09 - fosinopril (Wiki, WHO)
C09AA10 - trandolapril (Wiki, WHO)

C09B ACE INHIBITORS, COMBINATIONS

C09BA ACE inhibitors and diuretics
C09BA02 - enalapril and diuretics (Wiki, WHO)
C09BA03 - lisinopril and diuretics (Wiki, WHO)
C09BA04 - perindopril and diuretics (Wiki, WHO)
C09BA05 - ramipril and diuretics (Wiki, WHO)
C09BA06 - quinapril and diuretics (Wiki, WHO)
C09BA08 - cilazapril and diuretics (Wiki, WHO)

C09BB ACE inhibitors and calcium channel blockers
C09BB04 - perindopril and amlodipine (Wiki, WHO)
C09BB10 - trandolapril and verapamil (Wiki, WHO)

C09C ANGIOTENSIN II ANTAGONISTS, PLAIN

C09CA Angiotensin II antagonists, plain
C09CA01 - losartan (Wiki, WHO)
C09CA02 - eprosartan (Wiki, WHO)
C09CA03 - valsartan (Wiki, WHO)
C09CA04 - irbesartan (Wiki, WHO)
C09CA06 - candesartan (Wiki, WHO)
C09CA07 - telmisartan (Wiki, WHO)
C09CA08 - olmesartan medoxomil (Wiki, WHO)
C09CA09 - azilsartan medoxomil (Wiki, WHO)

C09D ANGIOTENSIN II ANTAGONISTS, COMBINATIONS

C09DA Angiotensin II antagonists and diuretics
C09DA01 - losartan and diuretics (Wiki, WHO)
C09DA02 - eprosartan and diuretics (Wiki, WHO)
C09DA03 - valsartan and diuretics (Wiki, WHO)
C09DA04 - irbesartan and diuretics (Wiki, WHO)
C09DA06 - candersartan and diuretics (Wiki, WHO)
C09DA07 - telmisartan and diuretics (Wiki, WHO)
C09DA08 - olmesartan medoxomil and diuretics (Wiki, WHO)
C09DA09 - azilsartant medoximil and diuretics (Wiki, WHO)

C09DB Angiotensin II antagonists and calcium channel blockers
C09DB04 - telmisartan and amlodipine (Wiki, WHO)

C09DX Angiotensin II antagonists, other combinations
C09DX04 - valsartan and sacubitril (Wiki, WHO)

C09X OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM

C09XA Renin-inhibitors
C09XA02 - aliskiren (Wiki, WHO)
C09XA52 - aliskiren and hydrochlorothiazide (Wiki, WHO)

C10 LIPID MODIFYING AGENTS

C10A LIPID MODIFYING AGENTS, PLAIN

C10AA HMG CoA reductase inhibitors
C10AA01 - simvastatin (Wiki, WHO)
C10AA02 - lovastatin (Wiki, WHO)
C10AA03 - pravastatin (Wiki, WHO)
C10AA04 - fluvastatin (Wiki, WHO)
C10AA05 - atorvastatin (Wiki, WHO)
C10AA07 - rosuvastatin (Wiki, WHO)

C10AB Fibrates
C10AB02 - bezafibrate (Wiki, WHO)
C10AB04 - gemfibrozil (Wiki, WHO)
C10AB05 - fenofibrate (Wiki, WHO)

C10AC Bile acid sequestrants
C10AC01 - colestyramine (Wiki, WHO)
C10AC02 - colestipol (Wiki, WHO)
C10AC04 - colesevelam (Wiki, WHO)

C10AD Nicotinic acid and derivatives
C10AD02 - nicotinic acid (Wiki, WHO)

C10AX Other lipid modifying agents
C10AX09 - ezetimibe (Wiki, WHO)
C10AX12 - lomitapide (Wiki, WHO)
C10AX13 - evolocumab (Wiki, WHO)
C10AX14 - alirocumab (Wiki, WHO)

C10B LIPID MODIFYING AGENTS, COMBINATIONS

C10BX HMG CoA reductase inhibitors, other combinations
C10BX03 - atorvastatin and amlodipine (Wiki, WHO)